Banzai International, Inc. (BNZI): Nasdaq/NYSE listing notice — Banzai gets Nasdaq deficiency notices for bid price and MVPHS

Banzai International, Inc.

Received two Nasdaq letters on April 3, 2024, for bid price and market value of publicly held shares non-compliance.
Common stock closing bid price below $1.00 for 30 consecutive business days.
Market value of publicly held shares below the required $15 million minimum for 30 consecutive business days.
Company has until September 30, 2024 to regain compliance for both deficiencies.
If not cured, may face delisting; company evaluating options including potential reverse stock split.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Banzai International, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

April 3, 2024, Banzai International, Inc. (the “ Company ”) received a letter from the staff at The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, for the 30 consecutive business days prior to the date of the letter, the Company’s Class A common stock, par value $0.0001 per share (the “ Common Stock ”), did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1). The letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or

View on SEC.gov

97 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Banzai International, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-089608

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.